India  

Vaccine drive accelerates, doses reach far corners of India

IndiaTimes Wednesday, 13 January 2021 ()
While SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and the National Institute of Virology, to 11 cities. It said it has donated 16.5 lakh doses to the Centre.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield

Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield 02:02

The first batch of Covaxin landed at the Delhi airport from Hyderabad on January 13. The Covid-19 vaccine by Bharat Biotech was brought in by two flights. An Air India flight landed with 3 boxes while the Vistara flight reached Delhi with 4 boxes. The boxes have been shifted to temperature controlled...

💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people. "Total vaccinators involved across India were 16,755. Total beneficiaries vaccinated across India--1,65,714. COVID19 vaccination drive was successful on Day 1. No case of post-vaccination hospitalisation reported so far," said Manohar Agnani, Additional Secretary of Union Health Ministry. "The Serum Institute of India (SII) produced COVISHIELD was supplied to all States and Union Territories (UT). Bharat Biotech's COVAXIN was supplied to 12 States. Total 3,351 sessions were held across the country with both the vaccines, said Health Ministry on COVID19 vaccine roll-out," he added. Watch the full video for more details.

Credit: HT Digital Content    Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made Covishield jabs respectively. Both didn't experience any side-effects and said that doubts regarding the inoculants are unfounded. Dr Suranjit Chatterjee of Apollo hospital, who is set to receive a shot soon, also weighed in on the controversy regarding Covaxin and its third phase trials. Watch the full video for more.

Credit: HT Digital Content    Duration: 08:15Published
Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

India may get four more COVID-19 vaccines soon, SII says work in progress

According to Suresh Jadhav, Executive Director of the Serum Institute, work is progressing rapidly on four more vaccines in addition to Covishield.
DNA

Hyderabad Hyderabad Capital of Telangana, India

Vaccines approved only after testing: G Kishan Reddy confident of efficacy [Video]

Vaccines approved only after testing: G Kishan Reddy confident of efficacy

Minister of State for Home Affairs G Kishan Reddy inaugurated vaccination drive at Gandhi Hospital in Hyderabad on January 16. On the rumours around the efficacy of the vaccine, G Kishan Reddy said that medicines tested in other countries are considered good but when our scientists toil and develop made in India medicines, people view it like that. He further assured that vaccines have been approved only after testing."I request people to not say such things. Medicines tested in other countries are considered good but when our scientists toil and develop made in India medicines, people view it like that. I request not to discuss things like this. Vaccines have been approved only after testing. I say this confidently that the vaccines will benefit everyone," said MoS Home Affairs G Kishan Reddy.

Credit: ANI    Duration: 01:11Published
COVID-19 vaccination drive begins in India [Video]

COVID-19 vaccination drive begins in India

The mega COVID-19 vaccination drive began in India on January 16. Prime Minister Narendra Modi launched the drive and around 100 healthcare workers will get vaccinated at each session site on the inaugural day. Manish Kumar, a sanitation worker, became the first person to receive COVID-19 vaccine jab at AIIMS. In the first phase of COVID-19 vaccination drive, healthcare workers will receive the vaccine. The beneficiaries reached to their respective health centres. Two COVID vaccines have been approved in India- Pune-based SII's 'Covishield' and Hyderabad-based Bharat Biotech's 'Covaxin'.

Credit: ANI    Duration: 01:41Published
Mega COVID vaccination drive to begin in India today [Video]

Mega COVID vaccination drive to begin in India today

The mega COVID-19 vaccination drive will begin in India on January 16. The preparations are underway at health centres across the country. Hyderabad's Nampally area hospital is all decked up to begin the drive today. Prime Minister Narendra Modi will launch the vaccination drive today via video-conferencing.

Credit: ANI    Duration: 01:26Published

AZD1222 AZD1222 Vaccine against COVID-19


BBV152 BBV152 Vaccine against COVID-19


National Institute of Virology Indian virology research institute

Bharat Biotech vaccine could've advantage over others on new strain, hopes ICMR DG [Video]

Bharat Biotech vaccine could've advantage over others on new strain, hopes ICMR DG

Director General of ICMR, Dr. Balram Bhargava, said that indigenously developed Bharat Biotech vaccine might have some advantages over other vaccines on the new strain of COVID that was found in UK. He said, "NIV scientists have successfully isolated the new virus strain and this will be tested against different vaccines. We hope potentially Bharat Biotech vaccine will have some advantages over other vaccines on this new strain because it is a whole virus." "New virus variant which is now more than 60% infective and creating havoc in the UK is worrisome. There are 29 patients in India with the same variant for which we should be cautious. We have been able to isolate the new virus very soon," added Dr. Balram Bhargava.

Credit: ANI    Duration: 01:49Published
PGIMER sends 80 random samples to Pune to check for new virus strain [Video]

PGIMER sends 80 random samples to Pune to check for new virus strain

Post Graduate Institute of Medical Education and Research Director Jagat Ram said that the institute has sent 80 random samples of patients who tested positive for COVID-19 since September to National Institute of Virology, Pune to ascertain if there is mutation in the virus. The PGIMER director informed that 20 samples each from the last four months have been sent.

Credit: ANI    Duration: 01:38Published

Indian Council of Medical Research Indian Council of Medical Research

India records 13,788 new COVID cases in last 24 hours [Video]

India records 13,788 new COVID cases in last 24 hours

As per the data released by Ministry of Health and Family Welfare (MoHFW), India on January 18 reported single-day spike of 13,788 new coronavirus cases in the last 24 hours. 145 deaths in the same period pushed the COVID-19 toll in the country to 1,52,419. India's confirmed cases of coronavirus stand at 1,05,71,773 which include 2,08,012 active infections. More than 1,02,11,342 people have recovered from the virus with 14,457 new discharges in last 24 hours. According to Indian Council of Medical Research (ICMR), a total of 5,48,168 samples were tested on January 17. Cumulative samples tested for COVID-19 till January 17 are 18,70,93,036.

Credit: ANI    Duration: 01:26Published
COVID-19: Total cases cross 1.05 crore-mark in India [Video]

COVID-19: Total cases cross 1.05 crore-mark in India

On January 16, total COVID-19 tally of India reached to 1,05,42,841. The country reported 15,158 new COVID-19 cases in last 24 hours and active cases stands at 2,11,033. With new 16,977 discharges, total number reached to 1,01,79715. 175 deaths were reported in last 24 hours, taking cumulative toll to 1,52,093. According to ICMR, total number of samples tested up to 11th January is 18,57,65,491 and of these, 8,03,090 samples were tested yesterday.

Credit: ANI    Duration: 01:52Published
COVID-19: Active cases in India dip to 2,10,l06 [Video]

COVID-19: Active cases in India dip to 2,10,l06

On January 15, India reported 15,677 new COVID-19 cases and 189 deaths in last 24 hours. The active cases stands at 2,10,l06. With new 15,848 discharges, total number reached to 1,01,62,082. 189 deaths were reported in last 24 hours, taking cumulative toll to 1,51,954. According to ICMR, total number of samples tested up to 14th January is 18,49,62,401 and of these, 7,30,096 samples were tested yesterday.

Credit: ANI    Duration: 01:45Published

You Might Like


Related videos from verified sources

Don't make mistake of ignoring 2nd dose of COVID-19 vaccine: PM Modi [Video]

Don't make mistake of ignoring 2nd dose of COVID-19 vaccine: PM Modi

Prime Minister Narendra Modi on January 16 reminded the people of India that the two doses of corona vaccine are very important. He said, "I want to remind people of the country that two doses of the..

Credit: ANI     Duration: 01:38Published
COVID-19 vaccination to be done at 81 locations in Delhi on Jan 16: Delhi Govt [Video]

COVID-19 vaccination to be done at 81 locations in Delhi on Jan 16: Delhi Govt

Ahead of COVID-19 vaccination drive, Delhi Chief Minister Arvind Kejriwal announced that the drive will be held at 81 locations in the national capital on January 16 and it will later increase to 175..

Credit: ANI     Duration: 01:44Published
Serum Institute of India dispatches 'Covishield' vaccine across India [Video]

Serum Institute of India dispatches 'Covishield' vaccine across India

The first batch of COVID-19 vaccine 'Covishield' was dispatched by Serum Institute of India (SII) in Pune across India on January 12. SII produces 70-80 million doses of the COVID vaccine every month...

Credit: ANI     Duration: 01:40Published

Related news from verified sources

Bharat Biotech clarifies on COVAXIN usage

Company releases fact sheet detailing possible adverse events and those who are eligible for the vaccine
Hindu Also reported by •IndiaTimesDNA

Bengal CM ‘science’ poser to Centre on Covaxin and Covishield

Bengal CM Mamata Banerjee on Monday asked whether “adequate scientific confirmation was available in support of” the vaccines Covishield and Covaxin, which...
IndiaTimes Also reported by •Hindu

Covishield, Covaxin are safest of Covid-19 vaccines, side-effects are negligible: VK Paul

Covishield and Covaxin, the two Covid-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects...
IndiaTimes Also reported by •HinduDNA